ArticleCell chemical biology2022

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer.

Ratika Kunder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.